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Abstract
Focal ischemia may induce pathological alterations in brain areas distant from the primary
lesion. In animal models, exofocal neuron death in the ipsilateral midbrain has been
described after occlusion of the middle cerebral artery (MCA). Using sequential magnetic
resonance imaging (T2- and diffusion-weighted) at 3 Tesla, we investigated acute ischemic
stroke patients on days 1, 2, 6, 8, and 10 after stroke onset. Sixteen consecutive patients
who had suffered a stroke involving the caudate nucleus and/or putamen of either hemi-
sphere were recruited into the study. Four additional patients with strokes sparing the cau-
date nucleus and putamen but encompassing at least one-third of the MCA territory served
as controls. Ischemic lesions involving striatal structures resulted in hyperintense lesions in
ipsilateral midbrain that emerged between days 6 and 10 after stroke and were not present
on the initial scans. In contrast, none of the control stroke patients developed secondary
midbrain lesions. Hyperintense lesions in the pyramidal tract or the brain stem caused by
degeneration of the corticospinal tract could be clearly distinguished from these secondary
midbrain gray matter lesions and were detectable from day 2 after ischemia. Co-registration
of high-resolution images with a digitized anatomic atlas revealed localization of secondary
lesions primarily in the substantia nigra pars compacta. Apparent diffusion coefficient
(ADC) values in the secondary lesions showed a delayed sharp decline through day 10.
Normalization of ADC values was observed at late measurements. Taken together, our
study demonstrates that striatal infarction elicits delayed degenerative changes in ipsilateral
substantia nigra pars compacta.
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Introduction
Midbrain changes associated with the loss of basal ganglia neurons have been described in
experimental models of brain ischemia in rats [1–6], mice [7, 8], gerbils [9], and cynomolgus
monkeys [10]. Magnetic resonance imaging (MRI) studies in experimental rodents demon-
strate transient exofocal signal changes in ipsilateral midbrain. In particular, apparent diffusion
coefficient (ADC) values show a significant delayed decrease and T2 values show a significant
delayed increase in the ipsilateral midbrain after occlusion of the middle cerebral artery [8, 11,
12]. On the histological level, these subacute MRI changes after experimental brain ischemia
are associated with alterations such as cellular swelling and changes in neuronal morphology
[11, 13].
The anecdotal histopathological reports of human autopsy brain tissue published so far
indicate nerve cell loss in the ipsilateral substantia nigra during the chronic phase after a large
infarction of the basal ganglia [14, 15]. Correspondingly, several MRI investigations of patients
with a stroke in the striatum also revealed a T2-weighted hyperintensity appearing as a sub-
acute exofocal alteration in the ipsilateral midbrain [16–19]. Here, we present a systematic pro-
spective study of a series of 16 consecutive patients with striatal infarction admitted to our
stroke unit between January 2009 and May 2010. Four additional patients whose ischemic
lesions spared the striatum served as controls. Sequential high-resolution anatomical MRI at 3
Tesla was used to delineate the emergence and the precise neuroanatomic localization of sec-
ondary MRI changes in the midbrain.
Methods
Patients and Controls
Data presented here were collected within the framework of a larger project designated the
"1000Plus study”, a prospective, single-center observational investigation [20, 21]. Study details
are posted at www.clinicaltrials.gov (NCT00715533). Based on the initial MRI assessment (see
below), 16 consecutive patients who had suffered an acute ischemic stroke involving the cau-
date nucleus and/or putamen of either hemisphere were recruited into the study (‘striatal
stroke patients’). Four additional patients who had suffered an acute ischemic stroke sparing
caudate nucleus and putamen but typically encompassing at least 1/3 of the middle cerebral
artery (MCA) cortical territory served as controls (‘control stroke patients’). Exclusion criteria
included severe aphasia or inability to provide informed consent, hemorrhagic stroke, severe
brain damage before admission, moderate to severe dementia (MMSE< 18) as well as contra-
indications to MRI. The protocol had been approved by the local ethics committee and written
informed consent was obtained prior to the study from each participant according to the Dec-
laration of Helsinki.
Image Acquisition
All MRI scans were acquired on a 3 T whole-body scanner (TIM Trio; Siemens AG, Erlangen,
Germany) dedicated entirely to clinical research. The baseline scan was obtained within 24
hours of stroke onset (day 1). Follow-up scans were performed on days 2, 6, 8, and 10. In some
patients, additional later scans were performed as shown in Table 1. On days 1 and 2, the MRI
protocol for this investigation included the following transversely-oriented sequences with a
consistent field-of-view of 230 mm: T2-weighted imaging (2D-FLASH; TA = 73 s; TE = 20
ms; TR = 620 ms; flip angle = 20°; matrix = 256 x 205; 25 slices with 5 mm thickness and 5.5
mm spacing); diffusion-weighted imaging (DWI) (SE-EPI; TA = 131 s; TE = 93 ms; TR = 7600
ms; matrix = 192 x 192, 50 slices with in-plane resolution of 1.2 mm, thickness of 2.5 mm and
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no interslice gap; 6 directions; b-values = 0 and 1000 s/mm2). On days 6, 8, and 10, the protocol
included DWI as described above as well as coronal T2-weighted imaging (TSE; TA = 157 s;
TE = 79 ms; TR = 5540 ms; matrix = 384 x 307; 30 slices with in-plane resolution of 0.6 mm,
thickness of 3 mm and spacing of 3.3 mm).
Postprocessing and Data Analysis
The following definitions apply: (a) ‘Primary ischemic lesion’ means the early T2 hyperintense
signal in the MCA territory. (b) The term ‘secondary MRI lesion’ is used for delayed T2/DWI
signal changes that emerge in the ipsilateral midbrain after stroke. ROIs of these two lesion
types were used independently in further analyses. As described in detail below, lesions were
identified separately on T2 and DWI scans. However, because of higher spatial resolution and
easier-to-process coronal orientation, volumetry and lesion maps were generated from T2
scans only. In general, DWI lesions matched T2 lesions well. However, because of different
scan techniques, we did not calculate the degree of overlap between DWI and T2 lesions.
For coronal T2 scans obtained on day 10 (or on the latest available scan before day 10),
binary masks distinguishing between the hyperintense-appearing primary and secondary
lesions, (coded as “1”), and non-infarcted areas (“0”) were generated for later usage as regions
of interests (ROI) and as the basis for subsequent volumetric measurements using the MRIcro
Table 1. MRI findings in striatal stroke patients and control stroke patients.
Patient no. Putamen Caudate Ncl. Pallidum <1/3 MCA cortex >1/3 MCA cortex Cm3 Day 6 Day 8 Day 10 Day 12 Day 72–144
1 X X X 0.8 – + +
2 X X X 126.1 – ++ ++ ++ –
3 X X 1.4 – – +
4 X X X 5.2 + ++ ++
5 X X X X 95.2 + n.d. n.d.
6 X X X X 37.9 + n.d. n.d.
7 X X 10.5 + n.d. n.d.
8 X X X X 21.3 – ++ ++
9 X X X X 14.4 – n.d. +
10 X X X X 41.0 + ++ ++ –
11 X X 4.8 – ++ ++ –
12 X X X X 187.7 – + +
13 X X X 43.5 – – –
14 X X X X 143.3 – – –
15 X X X X 89.9 – n.d. n.d.
16 X X X 133.0 – n.d. n.d.
17 – – – X 43.1 – n.d. n.d.
18 – – – X 11.0 – – –
19 – – – X 52.3 – – –
20 – – – X 21.6 – – –
Clear evidence of a secondary lesion is denoted by “+”. “++” denotes especially large secondary lesions. Patients 1 through 12 showed clear evidence for
delayed midbrain changes (DWI and T2) in ipsilateral substantia nigra occurring between days 6 and 10. Despite heavy motion artifacts, scans of patients
13 through 15 still showed some evidence for secondary midbrain changes (+). Several patients missed scans (n.d.). The primary reason for this was that
patients had either been transferred to a rehabilitation center or discharged. Control stroke patients (patients 17 through 20) did not show evidence of
secondary midbrain changes. Note that cortical involvement or the overall size of the infarct did not affect the development of secondary midbrain
changes. Normalization of ADC was observed at late measurements in single patients (days 72, 90, and 144).
doi:10.1371/journal.pone.0136483.t001
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software (http://www.mricro.com). Lesion segmentation was performed manually by an expe-
rienced investigator. To combine left- and right-sided infarcts into a single analysis, all images
with right-hemispheric strokes were mirrored right to left.
Furthermore, coronal T2-weighted images were co-registered with coronal section outlines
of a digitized atlas of the human brain [22, 23] using an in-house developed software
(“THAT”). In a first step, the interhemispheric midsagittal plane and the orthogonal plane
through the bicommissural line between the anterior and posterior commissures were deter-
mined as reference planes. Then the images were repetitively transformed (translation, rota-
tion, linear scaling) by the investigator with respect to structural landmarks (such as thalamus,
caudate nucleus, corticospinal tract, putamen, wall of the third ventricle) [22]. Transformations
generated during the co-registration procedure were used to spatially adjust the ROIs to the
stereotactic space of the digital atlas. The transformed image data as well as their corresponding
ROIs were subsequently re-sliced into two different iso-voxel spaces (1 x 1 x 1 mm; 0.25 x 0.25
x 0.25 mm) using SPM8 (Statistical Parametric Mapping; Wellcome Department for Cognitive
Neurology, University College London, UK) running on MATLAB 7.3 (The MathWorks, Inc.;
Natick, MA, USA). Finally, the relative frequencies of the primary and secondary lesions were
voxel-wisely calculated for both iso-voxel spaces and the resulting maps were subsequently
color-coded. These cluster maps were overlaid on the coronal section outlines of the digital
anatomic atlas to determine the lesion topography more precisely.
For the determination of changes in ADC in the secondary midbrain lesion as a function of
time, the respective ROI was delineated in axial DWI images (trace-weighted) obtained on day
10 or on the latest available scan between days 6 and 10, respectively, using MRIcro. Imaging
data of preceding scans were co-registered with this reference using SPM8 and the mean ADC
values of the lesions were quantified for all available time points. For the determination of con-
tralateral ADC values as an intra-subject reference value, ROIs were mirrored to the corre-
sponding contralateral neuroanatomic structures.
To visualize the spatial distribution of the primary lesion, DWI data sets on day 10 or on the
latest available scan, respectively, and their corresponding ROIs were additionally normalized
to the brain template provided by the International Consortium for Brain Mapping (ICBM)
using SPM8.
Statistical Analysis
Values are presented as means ± SEM. Ipsilateral and contralateral ADC measurements were
compared using paired t-tests.
Results
Sixteen consecutive striatal stroke patients and four control stroke patients were enrolled into
the study. Patients’ baseline characteristics are summarized in Table 2. The primary ischemic
Table 2. Baseline characteristics of study participants.
striatal stroke patients control stroke patients
No. 16 4
Age (mean ± S.E.M.) 70.4 ± 9.7 60.3 ± 26.3
Female gender, n (%) 8 (50) 3 (75)
NIHSS score, median (25th and 75th percentiles) 12 (5.5; 16.3) 5 (3; 9.8)
Right side of infarction, no. (%) 7 (44) 4 (100)
doi:10.1371/journal.pone.0136483.t002
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lesion was evaluated on day 2. Follow-up scans were performed as indicated in Table 1 using
T2-weighted and DWI scans.
Fig 1 illustrates the emergence of secondary exofocal midbrain changes. Primary ischemic
infarcts (Fig 1A and 1B) involving striatal structures resulted in hyperintense ipsilateral midbrain
lesions that emerged between days 6 and 10 after stroke (red arrows in Fig 1A and 1B). None of
the 4 patients with MCA infarctions sparing striatal structures showed any evidence of such sec-
ondary changes through day 10 (Table 1; patients 17–20). Note that exofocal midbrain changes
in gray matter have to be distinguished from hyperintense lesions in the pyramidal tract within
the brain stem white matter. The latter result fromWallerian degeneration of the corticospinal
tract (blue arrows in Fig 1B) and become clearly detectable from day 2 of stroke onwards.
Next, we studied the anatomic distributions and relative frequencies of the primary ischemic
lesions in relation to the emergence of secondary midbrain changes (Table 1; Figs 1C and 2A).
Infarcts associated with delayed exofocal midbrain changes (red color-coded in Fig 1C) consistently
Fig 1. Subacute hyperintensity in ipsilateral midbrain at a delayed time point after striatal stroke. (A, B) MRI scans of two exemplary patients showing
primary ischemic lesion confined to striatum (A) or involving striatum (B) in axial diffusion-weighted (DWI, left) and coronal T2-weighted (T2) imaging (white
arrows; 2nd from left). On the right side, coronal views through the midbrain display the development of an ipsilateral hyperintense lesion occuring between
days 6 to 10 after stroke (red arrows). Note that corticospinal degeneration (blue arrows in B) associated with cortical involvement is detectable before the
emergence of these secondary exofocal changes in midbrain. (C) Frequency of the anatomic distributions of the primary ischemic lesions (12 striatal stroke
and 4 control stroke patients). Lesions are overlayed on the ICBM human brain template. Infarcts associated with secondary midbrain changes are coded in
red, infarcts not associated with midbrain changes are coded in blue. Only frequencies of at least 25% are displayed. (D) Localization of secondary exofocal
midbrain changes (n = 12 striatal stroke patients). For the purpose of this illustration, secondary lesions (day 10 or latest available scan before day 10) were
adjusted to and superimposed on coronal and transverse T1-weighted images of a single patient.
doi:10.1371/journal.pone.0136483.g001
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involved striatal structures (caudate nucleus, putamen; Fig 2A). Similarly, we studied the frequen-
cies of the precise anatomic localizations of secondary exofocal lesions (Figs 1D and 2B). Co-regis-
tration with a digitized anatomic atlas [22, 23] showed that the core area of the secondary exofocal
midbrain lesions was consistently located in the pars compacta of the substantia nigra.
Finally, we measured ADC values of the ipsilateral secondary exofocal lesions over time. As
compared to the corresponding midbrain area of the contralateral hemisphere, ADC values in
the ipsilateral lesion showed a delayed sharp decline through day 10 (Fig 3).
Fig 2. Ischemic lesions of striatum elicit secondary changes in ipsilateral substantia nigra. (A) Color coding of the relative frequency of “ischemic”
voxels in the primary ischemic lesion of striatal stroke patients (n = 12) who subsequently developed secondary midbrain changes. Cd: Caudate nucleus
(nmax = 11); Pu: putamen (nmax = 10). (B) Color coding of the relative frequency of voxels showing secondary changes in midbrain in these patients. SNC:
substantia nigra, pars compacta (nmax = 9). SNR: substantia nigra, pars reticulata. Numbers ranging from -12.5 to +21.2 denote Talairach y-coordinates.
doi:10.1371/journal.pone.0136483.g002
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Discussion
This study has the following major findings: Ischemic lesions in the striatum lead to secondary
changes in ipsilateral midbrain gray matter. Co-registration of high-resolution images at 3 T
with a neuroanatomic atlas revealed that in human stroke patients these secondary midbrain
changes emerge particularly in the substantia nigra pars compacta. As compared to hyperin-
tense lesions in the pyramidal tract, which are caused by Wallerian degeneration of the corti-
cospinal tract, secondary midbrain hyperintensities were not present on the initial MRI scans
but appeared in a delayed fashion between days 6 and 10 after striatal stroke.
Cranial MRI provides an excellent anatomic definition of the location of the primary ische-
mic lesion and can also be used in the subacute and chronic phases after stroke. It is therefore
important that clinicians be aware of the delayed MRI changes described here so as not to con-
fuse them with a second stroke. As compared to an earlier study of striatal stroke patients at 0.5
T, which reported the first occurrence of a T2 hyperintensity in the midbrain, on average, at
Fig 3. Decline in ADC values in ipsilateral midbrain after striatal stroke. ADC values in the exofocal midbrain lesion (blue squares) showed a significant
delayed decrease relative to the corresponding nonlesioned (red circles) contralateral midbrain area (paired t-tests; day 6: p<0.02 [n = 12], day 8: p<0.005
[n = 9], day 10: p<0.0005 [n = 7]).
doi:10.1371/journal.pone.0136483.g003
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more than 14 days after stroke onset [16], our study at higher field strengths revealed that sec-
ondary changes in the substantia nigra are already underway during the first week after stroke.
The combination of a T2 hyperintensity and decreased ADC values suggests both cytotoxic
edema as well as vasogenic edema[24–26]. A similar pattern of MRI changes in midbrain as
described here for human stroke patients with striatal involvement has previously been
reported after occlusion of the middle cerebral artery in rats [12]. Conceivably, such secondary
changes may emerge as a novel target for neuroprotection with an extended time window [8,
27]. Importantly, in an experimental study in mice subjected to transient occlusion of the
MCA, the exofoxal T2 hyperintensity in the midbrain was associated with activation of micro-
glia and clearly preceded overt neuron loss [8].
While experimental stroke studies in rats mainly point to involvement of the pars reticulata
of the substantia nigra, our study, as well as an earlier MRI study in human patients [16],
found that secondary changes were especially prominent in, albeit not limited to, the pars com-
pacta (Fig 2B). Several explanations have been offered for this apparent discrepancy, including
differences in age, species, or the exact location of the primary ischemic lesion in the striatum
[16]. The striatonigral pathway predominantly projects to the pars reticulata of the ipsilateral
substantia nigra [28]. Destruction of this inhibitory GABAergic pathway after focal stroke may
result in disinhibition, and ultimately, delayed transneuronal (i.e., transsynaptic) degeneration,
primarily of neurons in the pars reticulata of the substantia nigra [2, 29]. By contrast, disrup-
tion of the nigrostriatal pathway may result in retrograde degeneration of dopaminergic (i.e.
tyrosine hydroxylase-expressing) neurons located primarily in the substantia nigra pars com-
pacta [30]. It is likely that both of these mechanisms also come into play in human striatal
stroke patients, depending on the precise neuroanatomic location of the primary striatal lesion.
What might be the clinical relevance of delayed exofocal neurodegeneration? In the current
study, no apparent clinical deterioration was observed with the onset of secondary midbrain
MRI changes. However, using a middle cerebral artery occlusion model in the mouse, we previ-
ously demonstrated that antidepressants prevent delayed neurodegeneration in the midbrain
and thereby attenuate the depression-like behavioral syndrome that typically evolves in the
subacute stages of recovery [31]. We speculate that, in stroke survivors, secondary neuronal
loss typically manifests in a delayed fashion in the form of subtle cognitive and neuropsychiat-
ric deficits [32], which may negatively impact long-term functional outcomes. Conceivably,
exofocal neuronal loss may also decrease a patient’s ‘cognitive reserve’, rendering him or her
more vulnerable to behavioral effects of subsequent brain pathology [32].
In conclusion, exofocal post-ischemic neuronal degeneration in the ipsilateral substantia
nigra depends on stroke topography and becomes detectable by MRI between days 6 and 10
after stroke. DWI and T2-weighted imaging at 3 T offer reliable detection of these secondary
midbrain changes. The further study of these delayed processes of lesion progression after
stroke may aid research in developing new strategies aimed at preventing secondary neuron
loss.
A potential caveat concerning our data is the relatively small size of the control group.
Although the current study focusses primarily on striatal infarctions as related to secondary
lesion development, which is only present in this group, the small sample size of the ‘non-stria-
tal’ control group and differences in baseline patient characteristics (e.g. NIHSS scores;
Table 2) may limit the generalizability of our findings.
Supporting Information
S1 Table. Individual ADC Values of EPND compared to contralateral side (please refer to
Fig 3). ADC Values (ADC [10−6 mm2/s +/- SD mean) of EPND (ROIs in axial DWI (ADC)) in
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12 patients ipsilateral to primary lesion (upper panel) compared to mirrored controlateral
ROIs (bottom panel). As mentioned in the manuscript, late measurements (days 12, 72 and
144) were done in single patients and show ADC normalization on day 72 and 144. P-values
for the comparison of ipsilateral and contralateral ADC values were calculated using Students
paired T-tests.
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